Insmed Incorporated
INSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$913,772 | -$749,567 | -$481,534 | -$434,654 |
| Dep. & Amort. | $11,013 | $10,579 | $10,331 | $14,182 |
| Deferred Tax | $0 | $0 | $0 | $17,689 |
| Stock-Based Comp. | $96,835 | $74,778 | $57,686 | $46,021 |
| Change in WC | -$3,177 | -$39,218 | $6,575 | -$58,580 |
| Other Non-Cash | $125,219 | $167,181 | $6,503 | $52,040 |
| Operating Cash Flow | -$683,882 | -$536,247 | -$400,439 | -$363,302 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$21,923 | -$13,288 | -$9,878 | -$7,289 |
| Net Acquisitions | $0 | $3,417 | $24,706 | -$6,704 |
| Inv. Purchases | -$1,577,252 | -$588,733 | -$99,706 | -$50,292 |
| Inv. Sales/Matur. | $1,016,000 | $375,000 | $75,000 | $56,996 |
| Other Inv. Act. | $0 | $0 | -$24,706 | -$56,996 |
| Investing Cash Flow | -$583,175 | -$223,604 | -$34,584 | -$64,285 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $147,390 | -$1,217 | $349,399 | $336,341 |
| Stock Issued | $1,084,124 | $152,475 | $292,153 | $269,886 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $109,506 | $17,181 | $151,721 | $6,319 |
| Financing Cash Flow | $1,341,020 | $168,439 | $793,273 | $612,546 |
| Forex Effect | -$1,307 | -$250 | -$996 | -$933 |
| Net Chg. in Cash | $72,656 | -$591,662 | $357,254 | $184,026 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $482,374 | $1,074,036 | $716,782 | $532,756 |
| End Cash | $555,030 | $482,374 | $1,074,036 | $716,782 |
| Free Cash Flow | -$705,805 | -$549,535 | -$410,317 | -$370,591 |